Cargando…

Selection of Multi-Drug Targets against Drug-Resistant Mycobacterium tuberculosis XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network

Tuberculosis remains the leading cause of death from a single pathogen. On the other hand, antimicrobial resistance (AMR) makes it increasingly difficult to deal with this disease. We present the hyperbolic embedding of the Mycobacterium tuberculosis protein interaction network (mtbPIN) of resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zahra, Noor ul Ain, Vagiona, Aimilia-Christina, Uddin, Reaz, Andrade-Navarro, Miguel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530867/ https://www.ncbi.nlm.nih.gov/pubmed/37762354 http://dx.doi.org/10.3390/ijms241814050

Ejemplares similares

Analysis of Huntington’s Disease Modifiers Using the Hyperbolic Mapping of the Protein Interaction Network
por: Vagiona, Aimilia-Christina, et al.
Publicado: (2022)

Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia
por: Ng, Kee Peng, et al.
Publicado: (2013)

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
por: Hameed, H. M. Adnan, et al.
Publicado: (2018)

A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
por: Singhal, Parul, et al.
Publicado: (2016)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

Classification of Mycobacterium tuberculosis DR, MDR,XDR Isolates and Identification of Signature MutationPattern of Drug Resistance
por: Prasanna, Akshatha, et al.
Publicado: (2019)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

Dynamics of a Protein Interaction Network Associated to the Aggregation of polyQ-Expanded Ataxin-1
por: Vagiona, Aimilia-Christina, et al.
Publicado: (2020)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro
por: Hassam, Muhammad, et al.
Publicado: (2022)

Extensively drug resistant tuberculosis (XDR-TB): A potential threat
por: Marwar, Anaga, et al.
Publicado: (2010)

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report
por: Izadi, Nafiseh, et al.
Publicado: (2014)

Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance
por: Kuan, Chee Sian, et al.
Publicado: (2015)

Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India
por: Paryani, Roma Haresh, et al.
Publicado: (2020)

Integrated bioinformatics based subtractive genomics approach to decipher the therapeutic function of hypothetical proteins from Salmonella typhi XDR H-58 strain
por: Khan, Kanwal, et al.
Publicado: (2022)

Extensively Drug-Resistant Tuberculosis (XDR-TB) - A Potential Threat in Ireland
por: Mc Laughlin, Anne Marie, et al.
Publicado: (2007)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Transmission Electron Microscopy of XDR Mycobacterium tuberculosis Isolates Grown on High Dose of Ofloxacin
por: Arjomandzadegan, Mohammad, et al.
Publicado: (2017)

Amendment to document "Health Insurance Scheme" (CERN/FC/1219)
Publicado: (1970)

XDR Tuberculosis: A Looming Threat
por: Sharma, Vishal, et al.
Publicado: (2009)

Whole genome sequence data of Mycobacterium tuberculosis XDR strain, isolated from patient in Kazakhstan
por: Daniyarov, Asset, et al.
Publicado: (2020)

Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB
por: Nonghanphithak, Ditthawat, et al.
Publicado: (2020)

Drug-Resistant Tuberculosis on the Balkan Peninsula: Determination of Drug Resistance Mechanisms with Xpert MTB/XDR and Whole-Genome Sequencing Analysis
por: Truden, Sara, et al.
Publicado: (2023)

Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
por: Utpat, Ketaki V., et al.
Publicado: (2023)

Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes
por: Surcouf, Corinne, et al.
Publicado: (2011)

Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa
por: Kapwata, Thandi, et al.
Publicado: (2017)

Extensively Drug-Resistant (XDR) Typhoid: Evolution, Prevention, and Its Management
por: Akram, Javed, et al.
Publicado: (2020)

Genome Subtraction and Comparison for the Identification of Novel Drug Targets against Mycobacterium avium subsp. hominissuis
por: Uddin, Reaz, et al.
Publicado: (2020)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017)

Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review
por: Varshney, Karan, et al.
Publicado: (2021)

Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases
por: Otchere, Isaac Darko, et al.
Publicado: (2023)

Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in Pakistan
por: Napier, Gary, et al.
Publicado: (2022)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
por: Heidary, Mohsen, et al.
Publicado: (2019)

The Genetic Structures of an Extensively Drug Resistant (XDR) Klebsiella pneumoniae and Its Plasmids
por: Li, Ling, et al.
Publicado: (2019)

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2013)

The Burden of MDR/XDR Tuberculosis in Coastal Plains Population of China
por: Yang, Xiujun, et al.
Publicado: (2015)

Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_duubausb37k6jmh4i0jus3v8kp